Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight.
Melasch J, Rullmann M, Hilbert A, Luthardt J, Becker GA, Patt M, Villringer A, Arelin K, Meyer PM, Lobsien D, Ding YS, Müller K, Sabri O, Hesse S, Pleger B. Melasch J, et al. Among authors: luthardt j. Int J Obes (Lond). 2016 May;40(5):779-87. doi: 10.1038/ijo.2015.216. Epub 2015 Oct 20. Int J Obes (Lond). 2016. PMID: 26620766 Free PMC article.
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.
Hesse S, Strecker K, Winkler D, Luthardt J, Scherfler C, Reupert A, Oehlwein C, Barthel H, Schneider JP, Wegner F, Meyer P, Meixensberger J, Sabri O, Schwarz J. Hesse S, et al. Among authors: luthardt j. J Neurol. 2008 Jul;255(7):1059-66. doi: 10.1007/s00415-008-0849-z. Epub 2008 May 2. J Neurol. 2008. PMID: 18446306 Clinical Trial.
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
Kendziorra K, Wolf H, Meyer PM, Barthel H, Hesse S, Becker GA, Luthardt J, Schildan A, Patt M, Sorger D, Seese A, Gertz HJ, Sabri O. Kendziorra K, et al. Among authors: luthardt j. Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):515-25. doi: 10.1007/s00259-010-1644-5. Epub 2010 Nov 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21069319
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knüpfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O. Hesse S, et al. Among authors: luthardt j. Int J Neuropsychopharmacol. 2011 Jun;14(5):606-17. doi: 10.1017/S1461145710001604. Epub 2011 Jan 14. Int J Neuropsychopharmacol. 2011. PMID: 21232166 Free article.
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
Barthel H, Luthardt J, Becker G, Patt M, Hammerstein E, Hartwig K, Eggers B, Sattler B, Schildan A, Hesse S, Meyer PM, Wolf H, Zimmermann T, Reischl J, Rohde B, Gertz HJ, Reininger C, Sabri O. Barthel H, et al. Among authors: luthardt j. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1702-14. doi: 10.1007/s00259-011-1821-1. Epub 2011 May 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21547601 Clinical Trial.
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.
Hesse S, Brust P, Mäding P, Becker GA, Patt M, Seese A, Sorger D, Zessin J, Meyer PM, Lobsien D, Laudi S, Habermann B, Füchtner F, Luthardt J, Bresch A, Steinbach J, Sabri O. Hesse S, et al. Among authors: luthardt j. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1001-11. doi: 10.1007/s00259-012-2078-z. Epub 2012 Feb 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22349718 Clinical Trial.
Altered serotonin transporter availability in patients with multiple sclerosis.
Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O. Hesse S, et al. Among authors: luthardt j. Eur J Nucl Med Mol Imaging. 2014 May;41(5):827-35. doi: 10.1007/s00259-013-2636-z. Epub 2014 Feb 22. Eur J Nucl Med Mol Imaging. 2014. PMID: 24562640
First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O, Becker GA, Meyer PM, Hesse S, Wilke S, Graef S, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Habermann B, Neuhaus P, Fischer S, Tiepolt S, Deuther-Conrad W, Barthel H, Schönknecht P, Brust P. Sabri O, et al. Among authors: luthardt j. Neuroimage. 2015 Sep;118:199-208. doi: 10.1016/j.neuroimage.2015.05.065. Epub 2015 May 30. Neuroimage. 2015. PMID: 26037057
43 results